University of California San Francisco
Give to UCSF
AIDS: The Struggle Continues
<p>Ellen Schell, RN, PhD, director of International Programs for the Global AIDS Interfaith Alliance and an associate adjunct professor in the UCSF School of Nursing, reflects on the uphill battle to combat AIDS in Malawi, a tiny, impoverished country of 15 million.</p>
30 Years of AIDS
<p>UCSF has been working for the past 30 years as a leader in AIDS basic and clinical research, patient care, policy development and community and global outreach – efforts that continue today.</p>
Blood Cell Test for HIV Treatment Monitoring is Cheaper but Just as Effective
A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.
AIDS Prevention 2.0: A Historic Opportunity to Halt HIV
<p>As we mark World AIDS Day this week, the U.S. Centers for Disease Control (CDC) and Prevention reports that more than a million Americans now live with the disease, and every year some 50,000 people in the United States alone are newly infected.</p>
New York Artist Brings the Beauty of Outdoors Inside UCSF
<p>The newest art installation at UCSF's Parnassus campus honors its longest-lived and most venerable inhabitants. </p>
First Bay Area Science Festival Draws Thousands
<p>More than 21,000 people converged to AT&T Park for the first annual Bay Area Science Festival, a spectacularly successful community outreach event sponsored in part by UCSF.</p>
Photo Project Captures UCSF's Multicultural Identity
<p>UCSF is capturing the multicultural identity of members of the University community in a new photo project called “100% You.”</p>
Low Level HIV in Bloodstream Not Linked With Inflammation or Death
Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.
UCSF Tapped for U.S. National AIDS Strategy Initiative
The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.